In addition, pancreatic cancer was also found to have upregulated METTL3 and downregulated ALKBH5 (m6A eraser) expression, and this dysregulation significantly influenced RNA methylation and resulted in poor clinical outcomes. The gene discussed is METTL3; the disease is familial pancreatic carcinoma.